Euroasian journal of hepato-gastroenterology

Register      Login

VOLUME 13 , ISSUE 2 ( July-December, 2023 ) > List of Articles

REVIEW ARTICLE

Recent Dengue Infection in Bangladesh: A Seasonal Endemic Progressing to Year-long Serious Health Concern

Sheikh Mohammad Fazle Akbar, Sakirul Khan, Musarrat Mahtab, Mamun Al Mahtab, Takaaki Yahiro, Shohael Mahmud Arafat, Mohammad Abdus Sattar Sarker, Provat Kumar Podder, Mohammad Shawkat Hossain, Faiz Ahmad Khandokar, Mohammad Rashedul Hassan, Md Abdur Rahim, Muhammad Ali Ashraf, Rajib Saha Rony, Akira Nishizono

Keywords : Bangladesh, Changing epidemiology, Dengue, Global emergency, Year-long endemic

Citation Information : Akbar SM, Khan S, Mahtab M, Al Mahtab M, Yahiro T, Arafat SM, Sarker MA, Podder PK, Hossain MS, Khandokar FA, Hassan MR, Rahim MA, Ashraf MA, Rony RS, Nishizono A. Recent Dengue Infection in Bangladesh: A Seasonal Endemic Progressing to Year-long Serious Health Concern. Euroasian J Hepatogastroenterol 2023; 13 (2):145-151.

DOI: 10.5005/jp-journals-10018-1408

License: CC BY-NC 4.0

Published Online: 26-12-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Dengue represents one of the most dangerous mosquito-borne viral diseases. Although the disease has been prevalent around the globe over the centuries, recent outbreaks of dengue have devasted the healthcare delivery system of many countries. Being a global infection, dengue virus (DENV) is endemically present mainly in Latin America and Caribbean countries as well as countries in South Asia. The recent outbreak of DENV infection has indicated an exceptional outbreak of DENV in some countries in South Asia. There has been a serious endemic of DENV during 2019. After a heterogeneous pause, another severe outbreak of DENV was reported in some Asian countries in 2023. Among the Asian countries, Bangladesh has reported an acute upsurge of DENV infection in 2023 with record numbers of fatalities. However, this pattern of DENV has not been detected in neighbors of Bangladesh, such as India or other countries in Southeast Asia. This provides an emergent task of dissecting the present DENV infection in Bangladesh from different angles to get insights for future containment of the DENV infection, not only in Bangladesh but also in other DENV endemic areas or DENV-native areas.


HTML PDF Share
  1. Go YY, Balasuriya UBR, Lee CK. Zoonotic encephalitides caused by arboviruses: Transmission and epidemiology of alphaviruses and flaviviruses. Clin Exp Vaccine Res 2014;3(1):58–77. DOI: 10.7774/cevr.2014.3.1.58.
  2. Higuera A, Ramírez JD. Molecular epidemiology of dengue, yellow fever, Zika and Chikungunya arboviruses: An update. Acta Trop 2019;190:99–111. DOI: 10.1016/j.actatropica.2018.11.010.
  3. Wilder-Smith A, Gubler DJ, Weaver SC, et al. Epidemic arboviral diseases: Priorities for research and public health. Lancet Infect Dis 2017;17(3):e101–e106. DOI: 10.1016/S1473-3099(16)30518-7.
  4. Gould E, Pettersson J, Higgs S, et al. Emerging arboviruses: Why today? One Health 2017;4:1–13. DOI: 10.1016/j.onehlt.2017.06.001.
  5. Harapan H, Michie A, Sasmono RT, et al. Dengue: A minireview. Viruses 2020;12(8):829. DOI: 10.3390/v12080829.
  6. Ferreira GLC. Global dengue epidemiology trends. Rev Inst Med Trop Sao Paulo 2012;54(suppl 18):S5–S6. DOI: 10.1590/s0036-46652012000700003.
  7. Wright WF, Pritt BS. Update: The diagnosis and management of dengue virus infection in North America. Diagn Microbiol Infect Dis 2012;73(3):215–220. DOI: 10.1016/j.diagmicrobio.2012.03.021.
  8. Parreira R, Sousa CA. Dengue fever in Europe: Could there be an epidemic in the future? Expert Rev Anti Infect Ther 2015;13(1):29–40. DOI: 10.1586/14787210.2015.982094.
  9. Eltom K, Enan K, El Hussein ARM, et al. Dengue virus infection in Sub-Saharan Africa between 2010 and 2020: A systematic review and meta-analysis. Front Cell Infect Microbiol 2021;11:678945. DOI: 10.3389/fcimb.2021.678945.
  10. Brathwaite Dick O, San Martin JL, Montoya RH, et al. The history of dengue outbreaks in the Americas. Am J Trop Med Hyg 2012;87(4):584–593. DOI: 10.4269/ajtmh.2012.11-0770.
  11. Tapia-Conyer R, Betancourt-Cravioto M, Méndez-Galván J. Dengue: An escalating public health problem in Latin America. Paediatr Int Child Health 2012;32(S1):14–17. DOI: 10.1179/2046904712Z.00000000046.
  12. Gómez-Dantés H, Willoquet JR. Dengue in the Americas: Challenges for prevention and control. Cad Saude Publica 2009;25(1):S19–S31. DOI: 10.1590/s0102-311x2009001300003.
  13. Pan American Health Organization. Epidemiological alert: Update on Dengue Situation in the Americas. [updated February 17, 2011; cited December 18, 2011]. Available from: http://new.paho.org/hq/dmdocuments/2011/EPI-Dengue-Alert-Feb17-2011.pdf.
  14. Martin San JL, Brathwaite O, Zambrano B, et al. The epidemiology of Dengue in the Americas over the last three decades: A worrisome reality. Am J Trop Med Hyg 2010;82(1):128–135. DOI: 10.4269/ajtmh.2010.09-0346.
  15. Tsheten T, Gray DJ, Clements ACA, et al. Epidemiology and challenges of dengue surveillance in the WHO Southeast Asia Region. Trans R Soc Trop Med Hyg 2021;115(6):583–599. DOI: 10.1093/trstmh/traa158.
  16. Bhatia R, Dash AP, Sunyoto T. Changing epidemiology of Dengue in Southeast Asia. WHO South East Asia J Public Health 2013;2(1):23–27. DOI: 10.4103/2224-3151.115830.
  17. Shrestha DB, Budhathoki P, Gurung B, et al. Epidemiology of Dengue in SAARC territory: A systematic review and meta-analysis. Parasit Vectors 2022;15(1):389. DOI: 10.1186/s13071-022-05409-1.
  18. Hassan MR, Azit NA, Fadzil SM, et al. Insecticide resistance of Dengue vectors in South East Asia: A systematic review. Afr Health Sci 2021;21(3):1124–1140. DOI: 10.4314/ahs.v21i3.21.
  19. Ranjit S, Kissoon N. Dengue hemorrhagic fever and shock syndromes. Pediatr Crit Care Med 2011;12(1):90–100. DOI: 10.1097/PCC.0b013e3181e911a7.
  20. Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microbiol Infect Dis 2007;30(5–6):329–340. DOI: 10.1016/j.cimid.2007.05.010.
  21. Bonna AS, Pavel SR, Mehjabin T, et al. Dengue in Bangladesh. Int J Infect Dis 2023:S1201-9712(23)00644-6. DOI: 10.1016/j.ijid.2023.06.020.
  22. Kayesh MEH, Khalil I, Kohara M, et al. Increasing dengue burden and severe dengue risk in Bangladesh: An overview. Trop Med Infect Dis 2023;8(1):32. DOI: 10.3390/tropicalmed8010032.
  23. Noor R. Reemergence of dengue virus in Bangladesh: Current fatality and the required knowledge. Tzu Chi Med J 2020;32(3):227–233. DOI: 10.4103/tcmj.tcmj_193_19.
  24. Burki T. Bangladesh faces record dengue outbreak. Lancet 2023;402(10400):439. DOI: 10.1016/S0140-6736(23)01610-0.
  25. Sharmin S, Viennet E, Glass K, et al. The emergence of Dengue in Bangladesh: Epidemiology, challenges and future disease risk. Trans R Soc Trop Med Hyg 2015;109(10):619–627. DOI: 10.1093/trstmh/trv067.
  26. Hossain MS, Noman AA, Mamun SMAA, et al. Twenty-two years of dengue outbreaks in Bangladesh: Epidemiology, clinical spectrum, serotypes, and future disease risks. Trop Med Health 2023;51(1):37. DOI: 10.1186/s41182-023-00528-6.
  27. Cousins S. Dengue rises in Bangladesh. Lancet Infect Dis 2019;19(2):138. DOI: 10.1016/S1473-3099(19)30008-8.
  28. Haider N, Asaduzzaman M, Hasan MN, et al. Bangladesh's 2023 Dengue outbreak – age/gender-related disparity in morbidity and mortality and geographic variability of epidemic burdens. Int J Infect Dis 2023;136:1–4. DOI: 10.1016/j.ijid.2023.08.026.
  29. Mutsuddy P, Tahmina Jhora S, Shamsuzzaman AKM, et al. Dengue stuation in Bangladesh: An epidemiological shift in terms of morbidity and mortality. Can J Infect Dis Med Microbiol 2019;2019:3516284. DOI: 10.1155/2019/3516284.
  30. Rafi A, Mousumi AN, Ahmed R, et al. Dengue epidemic in a non-endemic zone of Bangladesh: Clinical and laboratory profiles of patients. PLoS Negl Trop Dis 2020;14(10):e0008567. DOI: 10.1371/journal.pntd.0008567.
  31. Hasan MM, Sahito AM, Muzzamil M, et al. Devastating dengue outbreak amidst COVID-19 pandemic in Bangladesh: An alarming situation. Trop Med Health 2022;50(1):11. DOI: 10.1186/s41182-022-00401-y.
  32. Kumar S, Pattnaik R, Subhadra S, et al. Countering Dengue infection in Bangladesh in the backdrop of current outbreak. New Microbes New Infect 2023;55:101183. DOI: 10.1016/j.nmni.2023.101183.
  33. Haider N, Chang Y-M, Rahman M, et al. Dengue outbreaks in Bangladesh: Historic epidemic patterns suggest earlier mosquito control intervention in the transmission season could reduce the monthly growth factor and extent of epidemics. Curr Res Parasitol Vector Borne Dis 2021;1:100063. DOI: 10.1016/j.crpvbd.2021.100063.
  34. Yesmin S, Sarmin S, Ahammad AM, et al. Epidemiological Investigation of the 2019 Dengue Outbreak in Dhaka, Bangladesh. J Trop Med 2023;2023:8898453. DOI: 10.1155/2023/8898453.
  35. Hsan K, Hossain MM, Sarwar MS, et al. Unprecedented rise in dengue outbreaks in Bangladesh. Lancet Infect Dis 2019;19(12):1287. DOI: 10.1016/S1473-3099(19)30616-4.
  36. Mamun MA, Misti JM, Griffiths MD, et al. The dengue epidemic in Bangladesh: Risk factors and actionable items. Lancet 2019;394(10215):2149–2150. DOI: 10.1016/S0140-6736(19)32524-3.
  37. Islam MA, Hemo MK, Marzan AA, et al. A short communication of 2022 dengue outbreak in Bangladesh: A continuous public health threat. Ann Med Surg (Lond) 2023;85(6):3213–3217. DOI: 10.1097/MS9.0000000000000623.
  38. Islam MT, Rahman M, Sadia FJ. Outbreak of Dengue amid the COVID-19 pandemic: An emerged crisis for Bangladesh. Asia Pac J Public Health 2022;34(4):467–468. DOI: 10.1177/10105395211072841.
  39. Sharmin S, Glass K, Viennet E, et al. Geostatistical mapping of the seasonal spread of under-reported dengue cases in Bangladesh. PLoS Negl Trop Dis 2018;12(11):e0006947. DOI: 10.1371/journal.pntd.0006947.
  40. Malaker R, Sajib MSI, Malaker AR, et al. Genome sequence of a Dengue virus serotype 2 strain identified during the 2019 outbreak in Bangladesh. Microbiol Resour Announc 2021;10(1):e01246-20. DOI: 10.1128/MRA.01246-20.
  41. Mahmood R, Benzadid MS, Weston S, et al. Dengue outbreak 2019: Clinical and laboratory profiles of dengue virus infection in Dhaka city. Heliyon 2021;7(6):e07183. DOI: 10.1016/j.heliyon.2021.e07183.
  42. Islam J, Hu W. Heatwaves and Dengue outbreak in Bangladesh after COVID-19 pandemic – An urgent call for climate-driven early warning systems. Clin Infect Dis 2023:ciad625. DOI: 10.1093/cid/ciad625.
  43. Rahim R, Hasan A, Phadungsombat J, et al. Genetic analysis of Dengue virus in severe and non-severe cases in Dhaka, Bangladesh, in 2018–2022. Viruses 2023;15(5):1144. DOI: 10.3390/v15051144.
  44. ACAPS Briefing note – Bangladesh 2023 Dengue Outbreak (September 26, 2023). https://reliefweb.int/report/bangladesh/acaps-briefing-note-bangladesh-2023-dengue-outbreak-26-september-2023#:~:text=The%20dengue%20virus%20has%20affected,Manikganj%2C%20Cumilla%2C%20and%20Faridpur.
  45. WHO details unusual dengue surge in Bangladesh? https://www.cidrap.umn.edu/dengue/who-details-unusual-dengue-surge-bangladesh.
  46. Khan S, Akbar SMF, Nishizono A. Co-existence of a pandemic (SARS-CoV-2) and an epidemic (Dengue virus) at some focal points in Southeast Asia: Pathogenic importance, preparedness, and strategy of tackling. Lancet Reg Health Southeast Asia 2022;4:100046. DOI: 10.1016/j.lansea.2022.100046.
  47. Khan S, Akbar SMF, Yahiro T, et al. Dengue infections during COVID-19 period: Reflection of reality or elusive data due to effect of pandemic. Int J Environ Res Public Health 2022;19(17):10768. DOI: 10.3390/ijerph191710768.
  48. Teo A, Chua CLL, Chia PY, et al. Insights into potential causes of vascular hyperpermeability in Dengue. PLoS Pathog 2021;17(12):e1010065. DOI: 10.1371/journal.ppat.1010065.
  49. Sarker A, Dhama N, Gupta RD. Dengue virus neutralizing antibody: A review of targets, cross-reactivity, and antibody-dependent enhancement. Front Immunol 2023;14:1200195. DOI: 10.3389/fimmu.2023.1200195.
  50. Liu Y, Soh WT, Kishikawa JI, et al. An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies. Cell 2021;184(13):3452–3466.e18. DOI: 10.1016/j.cell.2021.05.032.
  51. Katzelnick LC, Coello Escoto A, Huang AT, et al. Antigenic evolution of dengue viruses over 20 years. Science 2021;374(6570):999–1004. DOI: 10.1126/science.abk0058.
  52. Rodriguez-Roche R, Sanchez L, Burgher Y, et al. Virus role during intraepidemic increase in dengue disease severity. Vector Borne Zoonotic Dis 2011;11(6):675–681. DOI: 10.1089/vbz.2010.0177.
  53. Chan KWK, Watanabe S, Jin JY, et al. A T164S mutation in the dengue virus NS1 protein is associated with greater disease severity in mice. Sci Transl Med 2019;11(498):eaat7726. DOI: 10.1126/scitranslmed.aat7726.
  54. Carabali M, Hernandez LM, Arauz MJ, et al. Why are people with Dengue dying? A scoping review of determinants for dengue mortality. BMC Infect Dis 2015:15:301. DOI: 10.1186/s12879-015-1058-x.
  55. Beatty ME, Stone A, Fitzsimons DW, et al. Best practices in dengue surveillance: A report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis 2010;4(11):e890. DOI: 10.1371/journal.pntd.0000890.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.